Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Ceapro Inc V.CZO

Alternate Symbol(s):  CRPOF

Ceapro Inc. is a Canada-based biotechnology company. The Company is involved in the development of extraction technology and the application of this technology to the production of extracts and active ingredients from oats and other renewable plant resources. Its primary business activities relate to the development and commercialization of natural products for personal care, cosmetic, human, and animal health industries using technology, natural, renewable resources, and developing products, technologies, and delivery systems. The Company's products include a commercial line of natural active ingredients, including beta glucan, avenanthramides (colloidal oat extract), oat powder, oat oil, oat peptides, and lupin peptides, a commercial line of natural anti-aging skincare products, utilizing active ingredients, including beta glucan and avenanthramides and veterinary therapeutic products, including an oat shampoo, an ear cleanser, and a dermal complex/conditioner.


TSXV:CZO - Post by User

Comment by Minty_33on May 04, 2021 1:17pm
101 Views
Post# 33124267

RE:RE:RE:RE:RE:RE:RE:Stop Talking and Start Doing

RE:RE:RE:RE:RE:RE:RE:Stop Talking and Start Doing"Hopefully if an equity raise is needed they would get their story out there"

That's what I've been eluding to for quite some time. In order for the story to get out though, there needs to be a communication plan. It's very clear that Gilles doesn't have one. Does any shareholder want to have a money raise at these low prices? I don't think so. It's obvious that in order to complete the plant in Germany, more funds will be required. How is Gilles going to finance this seemingly major undertaking? We've heard in the past about licensing deals, cash upfront, royalties and milestone payments blah blah....and that probably wouldn't be sufficient to put the shovel in the ground anyway. As previously posted, Gilles lackadaisical M/O is hurting the future prospects of this company. Ceapro has a current market cap of 51 Million with sales North of 15 Million a year and profitable. Draganfly (DFLY) which I have done well on on has a market cap of 160 Million with 4.3 Million and losing money (albeit the company is growing) . Why is it trading at a premium so to speak? Because they know how to tell the story! And people have confidence in the CEO to execute deals. When it comes to growth, I hope the company doesn't settle for that Mickey Mouse deal as a result of the reticence that Gilles lives by. 
The story must get out now so when the money is needed the company will will be able to acquire more as a result of the valuation. 


<< Previous
Bullboard Posts
Next >>